ASTELLAS PHARMA earnings per share and revenue

4503/N earnings per share for the last quarter are -2.03 MXN whereas the estimation was -0.32 MXN which accounts for -542.44% surprise. Company revenue for the same period amounts to 45.40 B MXN despite the estimated figure of 41.60 B MXN. Estimated earnings per share for the next quarter are 1.07 MXN, and revenue is expected to reach 44.42 B MXN. Also watch annual changes over time to get a bigger picture of 4503/N earnings per share and revenue dynamics.